Drug intelligence / Profile preview

clindamycin + benzoyl peroxide

Development stage
Approved
Lead developer
Stiefel
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Clindamycin + benzoyl peroxide is a fixed-dose topical combination used primarily for the treatment of acne vulgaris in patients aged 12 years and older. It combines two active ingredients with complementary mechanisms: - **Clindamycin** is a lincosamide antibiotic that inhibits bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome, thereby preventing *Cutibacterium acnes* (formerly *Propionibacterium acnes*) from growing and replicating. - **Benzoyl peroxide** is an antiseptic and keratolytic agent that kills *C. acnes* by releasing free radical oxygen species to oxidize bacterial proteins. It also helps reduce sebum production and prevents clogged pores. This dual mechanism targets both the microbial cause of acne and associated inflammation while reducing resistance risk due to their different modes of action[1][2][3][4][5].

Brand names
BenzaclinAcanyaNeuac
Other names
clindamycin/benzoyl peroxidebenzoyl peroxide/clindamycin
02

Targets

C. acnes (Cutibacterium acnes)Bacterial 50S ribosomal subunit

Beyond the preview

Go deeper on clindamycin + benzoyl peroxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clindamycin + benzoyl peroxide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call